These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1369812

  • 21. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE, Lu L, Cooper S, Tushinski R, Mochizuki D, Rubin BY, Gillis S, Williams DE.
    J Immunol; 1988 Dec 01; 141(11):3852-62. PubMed ID: 3053902
    [Abstract] [Full Text] [Related]

  • 22. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
    Wodnar-Filipowicz A, Chklovskaia E, Manz CY, Lyman SD, Nissen C.
    Exp Hematol; 1997 Jul 01; 25(7):573-81. PubMed ID: 9216732
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F, Rappa DA, Laky K, Carsons SE.
    Stem Cells; 1995 Mar 01; 13(2):186-97. PubMed ID: 7540472
    [Abstract] [Full Text] [Related]

  • 26. Effect of c-kit ligand (stem cell factor) in combination with interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3, on eosinophil lineage.
    Kobayashi H.
    Int J Hematol; 1993 Aug 01; 58(1-2):21-6. PubMed ID: 7693027
    [Abstract] [Full Text] [Related]

  • 27. The relationship between different high proliferative potential colony-forming cells in mouse bone marrow.
    Kriegler AB, Verschoor SM, Bernardo D, Bertoncello I.
    Exp Hematol; 1994 May 01; 22(5):432-40. PubMed ID: 7513652
    [Abstract] [Full Text] [Related]

  • 28. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS, Plunkett JM, Schendel P, van de Ven C.
    Exp Hematol; 1994 Oct 01; 22(11):1118-23. PubMed ID: 7523164
    [Abstract] [Full Text] [Related]

  • 29. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
    Ganser A, Hoelzer D.
    Hematol Oncol Clin North Am; 1992 Jun 01; 6(3):633-53. PubMed ID: 1377194
    [Abstract] [Full Text] [Related]

  • 30. Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells.
    Hirao A, Takaue Y, Kawano Y, Sato J, Suzue T, Abe T, Saito S, Kawahito M, Okamoto Y, Makimoto A.
    Stem Cells; 1995 Jan 01; 13(1):47-53. PubMed ID: 7536512
    [Abstract] [Full Text] [Related]

  • 31. Myeloid hemopoietic growth factors. Review article.
    Vrhovac R, Kusec R, Jaksić B.
    Int J Clin Pharmacol Ther Toxicol; 1993 May 01; 31(5):241-52. PubMed ID: 8314653
    [Abstract] [Full Text] [Related]

  • 32. Clinical use of recombinant human hematopoietic growth factors (GM-CSF, IL-3, EPO) in patients with myelodysplastic syndrome.
    Herrmann F, Mertelsmann R, Lindemann A, Ottmann OG, Seipelt G, Oster W, Hoelzer D, Ganser A.
    Biotechnol Ther; 1991 May 01; 2(3-4):299-311. PubMed ID: 1845132
    [Abstract] [Full Text] [Related]

  • 33. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M, Ganser A.
    Ther Umsch; 1996 Nov 01; 53(11):863-73. PubMed ID: 8984692
    [Abstract] [Full Text] [Related]

  • 34. Biology and clinical applications of hemopoietins in pediatric practice.
    Furman WL, Crist WM.
    Pediatrics; 1992 Nov 01; 90(5):716-28. PubMed ID: 1383919
    [No Abstract] [Full Text] [Related]

  • 35. Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor.
    Shitara T, Ijima H, Yugami S, Sotomatu M, Kuroume T.
    Am J Pediatr Hematol Oncol; 1994 May 01; 16(2):167-72. PubMed ID: 7513137
    [Abstract] [Full Text] [Related]

  • 36. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 01; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 37. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.
    McNiece IK, Langley KE, Zsebo KM.
    Exp Hematol; 1991 Mar 01; 19(3):226-31. PubMed ID: 1704845
    [Abstract] [Full Text] [Related]

  • 38. [Stimulation of human megakaryopoiesis in vitro with different growth factors. Potential clinical applications].
    Ratajczak J, Kuczyński W, Ratajczak MZ.
    Pol Arch Med Wewn; 1994 May 01; 91(5):356-62. PubMed ID: 8084812
    [Abstract] [Full Text] [Related]

  • 39. Hematopoietic cytokines: from biology and pathophysiology to clinical application.
    Mertelsmann R.
    Leukemia; 1993 Aug 01; 7 Suppl 2():S168-77. PubMed ID: 8361225
    [No Abstract] [Full Text] [Related]

  • 40. [Hematopoietic growth factors].
    Niemeyer C.
    Kinderkrankenschwester; 1993 Mar 01; 12(3):101-2. PubMed ID: 8489936
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.